Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
thioredoxin reductase | 8 | 0 | 0 | 8 |
aldehyde dehydrogenase 1 family, member A1 | 13 | 0 | 0 | 13 |
IDH1 | 4 | 0 | 0 | 4 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
Protein skinhead-1 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Chain A, farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
Farnesyl pyrophosphate synthase | 0 | 4 | 0 | 4 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
Farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 7 | 0 | 0 | 7 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
NFKB1 protein, partial | 3 | 0 | 0 | 3 |
GLS protein | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
alpha-galactosidase | 3 | 0 | 0 | 3 |
euchromatic histone-lysine N-methyltransferase 2 | 12 | 0 | 0 | 12 |
cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
chromobox protein homolog 1 | 8 | 0 | 0 | 8 |
flap endonuclease 1 | 3 | 0 | 0 | 3 |
DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
lethal factor (plasmid) | 4 | 0 | 0 | 4 |
Cytochrome P450 3A4 | 0 | 12 | 0 | 16 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 2 | 0 | 2 |
ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
Chain A, Ferritin light chain | 8 | 0 | 0 | 8 |
interleukin 8 | 3 | 0 | 0 | 3 |
acetylcholinesterase | 5 | 0 | 0 | 5 |
RAR-related orphan receptor gamma | 14 | 0 | 0 | 14 |
SMAD family member 2 | 8 | 0 | 0 | 8 |
ATAD5 protein, partial | 3 | 0 | 0 | 3 |
Fumarate hydratase | 3 | 0 | 0 | 3 |
SMAD family member 3 | 8 | 0 | 0 | 8 |
TDP1 protein | 20 | 0 | 0 | 20 |
GLI family zinc finger 3 | 16 | 0 | 0 | 16 |
Microtubule-associated protein tau | 7 | 0 | 0 | 7 |
AR protein | 20 | 0 | 0 | 20 |
thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 7 | 0 | 0 | 7 |
EWS/FLI fusion protein | 9 | 0 | 0 | 9 |
glucocorticoid receptor [Homo sapiens] | 16 | 0 | 0 | 16 |
retinoic acid nuclear receptor alpha variant 1 | 16 | 0 | 0 | 16 |
retinoid X nuclear receptor alpha | 13 | 0 | 0 | 13 |
estrogen-related nuclear receptor alpha | 16 | 0 | 0 | 16 |
farnesoid X nuclear receptor | 9 | 0 | 0 | 9 |
pregnane X nuclear receptor | 13 | 0 | 0 | 13 |
estrogen nuclear receptor alpha | 28 | 0 | 0 | 28 |
G | 10 | 0 | 0 | 10 |
polyprotein | 3 | 0 | 0 | 3 |
P53 | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 9 | 0 | 0 | 9 |
peroxisome proliferator activated receptor gamma | 10 | 0 | 0 | 10 |
arylsulfatase A | 6 | 0 | 0 | 6 |
aryl hydrocarbon receptor | 6 | 0 | 0 | 6 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 13 | 0 | 0 | 13 |
thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
activating transcription factor 6 | 6 | 0 | 0 | 6 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 7 | 0 | 0 | 7 |
Histone H2A.x | 6 | 0 | 0 | 6 |
Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
peripheral myelin protein 22 isoform 1 | 4 | 0 | 0 | 4 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform 2 | 18 | 0 | 0 | 18 |
heat shock protein beta-1 | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 15 | 0 | 0 | 15 |
geminin | 14 | 0 | 0 | 14 |
peripheral myelin protein 22 | 9 | 0 | 0 | 9 |
survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 16 | 0 | 0 | 16 |
Gamma-aminobutyric acid receptor subunit pi | 5 | 0 | 0 | 5 |
ATP-binding cassette sub-family C member 3 | 0 | 18 | 0 | 18 |
Multidrug resistance-associated protein 4 | 0 | 19 | 0 | 20 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 5 | 0 | 0 | 5 |
Bile salt export pump | 0 | 21 | 0 | 21 |
Interferon beta | 13 | 0 | 0 | 13 |
HLA class I histocompatibility antigen, B alpha chain | 10 | 0 | 0 | 10 |
Cellular tumor antigen p53 | 12 | 0 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit delta | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 0 | 0 | 5 |
Glutamate receptor 2 | 5 | 0 | 1 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 0 | 0 | 5 |
Nuclear receptor ROR-gamma | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 0 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 0 | 0 | 5 |
GABA theta subunit | 5 | 0 | 0 | 5 |
Inositol hexakisphosphate kinase 1 | 10 | 0 | 0 | 10 |
Canalicular multispecific organic anion transporter 1 | 0 | 18 | 0 | 18 |
ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
Ataxin-2 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit epsilon | 5 | 0 | 0 | 5 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 10 | 0 | 0 | 10 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain B, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin Complex With Biotin | 0 | 0 | 1 | 1 |
Chain D, Circularly Permuted Core-streptavidin E51/a46 | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 0 | 1 | 0 | 1 |
green fluorescent protein, partial | 0 | 1 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 6 | 0 | 0 | 6 |
insulin-degrading enzyme isoform 1 | 0 | 0 | 1 | 1 |
Streptavidin | 0 | 0 | 1 | 1 |
Receptor-type tyrosine-protein phosphatase beta | 0 | 0 | 0 | 1 |
Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
Chain A, Cruzipain | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
relaxin receptor 1 isoform 1 | 2 | 0 | 0 | 2 |
Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
PPM1D protein | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 5 | 0 | 0 | 5 |
nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
Vitamin D-binding protein | 0 | 0 | 1 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 2 |
Androgen receptor | 0 | 5 | 2 | 9 |
Cytochrome P450 2D6 | 0 | 4 | 0 | 4 |
Vitamin D3 receptor | 0 | 1 | 2 | 4 |
Cytochrome P450 2C9 | 0 | 4 | 0 | 5 |
Vitamin D3 receptor | 0 | 1 | 1 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 1 | 1 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Transporter | 0 | 2 | 0 | 2 |
Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 14 | 0 | 0 | 14 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
estrogen receptor 2 (ER beta) | 9 | 0 | 0 | 9 |
progesterone receptor | 10 | 0 | 0 | 10 |
cytochrome P450 2D6 | 14 | 0 | 0 | 14 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 8 | 0 | 0 | 8 |
Sex hormone-binding globulin | 0 | 1 | 3 | 4 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Corticosteroid-binding globulin | 0 | 3 | 0 | 3 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 3 | 0 | 3 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 3 | 3 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Steryl-sulfatase | 0 | 0 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 4 | 0 | 6 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 3 |
Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 6 |
potassium voltage-gated channel subfamily H member 2 isoform d | 7 | 0 | 0 | 7 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 10 | 0 | 10 |
Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 8 | 7 | 29 |
Integrase | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 5 | 0 | 5 |
67.9K protein | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform a | 7 | 0 | 0 | 7 |
Albumin | 0 | 0 | 4 | 12 |
Chain A, Sex Hormone-Binding Globulin | 0 | 0 | 1 | 1 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
Plasma kallikrein | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 5 | 1 | 7 |
Progesterone receptor | 0 | 1 | 0 | 1 |
Progesterone receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Sex hormone-binding globulin | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 2 |
Androgen receptor | 0 | 10 | 1 | 11 |
Androgen receptor | 0 | 1 | 1 | 2 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 0 | 1 | 1 |
Cannabinoid receptor 2 | 0 | 2 | 1 | 3 |
Muscarinic acetylcholine receptor | 0 | 1 | 0 | 1 |
Neuropeptide FF receptor 2 | 0 | 0 | 0 | 1 |
ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 0 | 0 | 1 | 1 |
Glutamate receptor 3 | 0 | 0 | 1 | 1 |
Glutamate receptor 4 | 0 | 0 | 1 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 1 | 3 |
Cannabinoid receptor 1 | 0 | 2 | 1 | 4 |
Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
Cannabinoid receptor 2 | 0 | 2 | 1 | 4 |
D(3) dopamine receptor | 0 | 6 | 1 | 7 |
Cannabinoid receptor 1 | 0 | 3 | 0 | 3 |
N-arachidonyl glycine receptor | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Lysophosphatidylserine lipase ABHD12 | 0 | 1 | 0 | 1 |
Monoglyceride lipase | 0 | 1 | 0 | 1 |
Monoacylglycerol lipase ABHD6 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 2 | 0 | 2 | 0 | 2 |
G-protein coupled receptor 55 | 0 | 1 | 1 | 2 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, Pol Polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol Polyprotein | 0 | 1 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
caspase-3 | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
Prothrombin | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 1A | 0 | 6 | 0 | 8 |
Cytochrome P450 2B6 | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 0 | 0 | 2 |
Microsomal triglyceride transfer protein large subunit | 0 | 2 | 0 | 2 |
Spike glycoprotein | 7 | 0 | 0 | 7 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 2 | 0 | 3 |
Envelope glycoprotein gp160 [Cleaved into: Surface protein gp120 | 0 | 1 | 0 | 1 |
Protease | 0 | 11 | 5 | 31 |
Fructose-1,6-bisphosphatase 1 | 0 | 0 | 0 | 2 |
Reverse transcriptase | 0 | 2 | 2 | 4 |
Cholesterol 24-hydroxylase | 0 | 0 | 1 | 1 |
Sodium-dependent serotonin transporter | 0 | 0 | 1 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
endonuclease IV | 3 | 0 | 0 | 3 |
ClpP | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 4 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
Transitional endoplasmic reticulum ATPase | 0 | 1 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 3 |
Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 0 | 0 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Amino acid transporter | 0 | 1 | 0 | 1 |
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
Chain A, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain B, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain A, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain B, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain A, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain A, HIV-II PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-II PROTEASE | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 2 | 0 | 2 |
Chain B, POL polyprotein | 0 | 2 | 0 | 2 |
Chain A, POL polyprotein | 0 | 2 | 0 | 2 |
Chain B, POL polyprotein | 0 | 2 | 0 | 2 |
Chain A, HIV-1 protease | 0 | 1 | 0 | 1 |
Chain B, HIV-1 protease | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 6 | 0 | 6 |
Gag-Pol polyprotein | 0 | 3 | 0 | 3 |
Gag polyprotein | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 4 | 0 | 4 |
ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 5 |
Replicase polyprotein 1ab | 0 | 2 | 0 | 2 |
Replicase polyprotein 1ab | 0 | 3 | 0 | 3 |
Alpha-1B adrenergic receptor | 0 | 6 | 0 | 6 |
Substance-K receptor | 0 | 8 | 0 | 8 |
Alpha-1D adrenergic receptor | 0 | 5 | 0 | 5 |
Thromboxane-A synthase | 0 | 4 | 0 | 4 |
Gag-Pol polyprotein | 0 | 4 | 0 | 4 |
Alpha-1A adrenergic receptor | 0 | 6 | 0 | 6 |
Thromboxane-A synthase | 0 | 0 | 0 | 3 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 3 |
Multidrug and toxin extrusion protein 2 | 0 | 3 | 0 | 3 |
Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
Protease | 0 | 9 | 4 | 14 |
Protease | 0 | 1 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
perilipin-5 | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Glutathione reductase, mitochondrial | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M5 | 0 | 5 | 0 | 5 |
Alpha-2A adrenergic receptor | 0 | 4 | 0 | 4 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 0 | 3 |
Alpha-2B adrenergic receptor | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
D(1A) dopamine receptor | 0 | 6 | 0 | 6 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
Histamine H2 receptor | 0 | 4 | 0 | 4 |
Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 1B | 0 | 6 | 0 | 6 |
Histamine H1 receptor | 0 | 4 | 0 | 4 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 3 | 0 | 3 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Hsf1 protein | 0 | 0 | 2 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
Capsid protein | 0 | 1 | 1 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 2 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
bioA | 0 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 5 | 0 | 0 | 5 |
DNA polymerase beta | 4 | 0 | 0 | 4 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
glucocerebrosidase | 2 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | 0 | 1 | 0 | 1 |
Chain A, ASPARTYLPROTEASE | 0 | 1 | 0 | 1 |
Chain B, ASPARTYLPROTEASE | 0 | 1 | 0 | 1 |
Smad3 | 4 | 0 | 0 | 4 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Cruzipain | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 6 | 0 | 6 |
Delta-type opioid receptor | 0 | 4 | 1 | 5 |
Kappa-type opioid receptor | 0 | 6 | 0 | 6 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 3 | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Reverse Transcriptase | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Reverse Transcriptase | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Reverse Transcriptase | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Reverse Transcriptase | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Reverse Transcriptase | 0 | 1 | 0 | 1 |
Chain A, Reverse transcriptase/ribonuclease H | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Imidazoleglycerol-phosphate dehydratase | 0 | 1 | 0 | 1 |
Ryanodine receptor 1 | 0 | 1 | 0 | 1 |
Exoribonuclease H | 0 | 2 | 0 | 2 |
Cardiac ryanodine receptor 2 | 0 | 1 | 0 | 1 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, L-ARGININE\\:GLYCINE AMIDINOTRANSFERASE | 0 | 1 | 0 | 1 |
Caspase-7 | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
Luciferase | 2 | 0 | 0 | 2 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
vasopressin V1b receptor | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Tumor necrosis factor | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
Adenosine receptor A2b | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
Chitotriosidase-1 | 0 | 2 | 1 | 3 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Endochitinase B1 | 0 | 2 | 1 | 3 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 2B1 | 0 | 4 | 0 | 5 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Insulin receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
pregnane X receptor | 1 | 0 | 0 | 1 |
Monocarboxylate transporter 4 | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 2 | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 1 | 0 | 0 | 0 | 1 |
C-terminal-binding protein 2 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 1 | 3 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
D | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Transporter | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Chain A, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain A, Endothiapepsin | 0 | 1 | 0 | 1 |
Chain A, Endothiapepsin | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
Vasopressin V1a receptor | 0 | 4 | 0 | 4 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Plasmepsin V | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Protease | 0 | 0 | 1 | 1 |
Chain B, Protease | 0 | 0 | 1 | 1 |
Chain A, Protease | 0 | 0 | 1 | 1 |
Chain B, Protease | 0 | 0 | 1 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 1 | 2 |
Cholecystokinin receptor type A | 0 | 2 | 2 | 4 |
Gastrin/cholecystokinin type B receptor | 0 | 2 | 2 | 4 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
Thymidine kinase 2 | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecD | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecB | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecC | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 3 | 0 | 5 |
Thymidine kinase, cytosolic | 0 | 1 | 0 | 2 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
DNA-binding protein Ikaros | 0 | 0 | 0 | 1 |
DNA damage-binding protein 1 | 0 | 1 | 1 | 2 |
Protein cereblon | 0 | 2 | 1 | 4 |
Chain A, Protein (hiv-1 Protease) | 0 | 1 | 0 | 1 |
Chain B, Protein (hiv-1 Protease) | 0 | 1 | 0 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Cathepsin D | 0 | 1 | 0 | 1 |
Pepsin A-5 | 0 | 1 | 0 | 1 |
Cathepsin E | 0 | 1 | 0 | 1 |
CAAX prenyl protease 1 homolog | 0 | 1 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 0 | 0 | 1 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
Ectonucleoside triphosphate diphosphohydrolase 1 | 0 | 0 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
DNA polymerase beta | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |